v3.26.1
Note 15 - Phaseone Divestiture (Tables)
 12 Months Ended
Dec. 31, 2025
Wound Care [Member]  
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   

As of

December 31,

2024

  

ASSETS

        

Current assets:

        

Accounts receivable, net

   $ 6  

Inventory

     48  

Total current assets, discontinued operations

   $ 54  
         

LIABILITIES

        

Liabilities:

        

Current liabilities:

        

Accounts payable

   $ 43  

Total current liabilities, discontinued operations

   $ 43  
   

For the years ended

December 31,

 
   

2025

    

2024

  
                 

Net sales

   $ 122     $ 258  

Cost of goods sold

     75       147  

Gross profit

     47       111  

Operating expenses:

                

Research and development

     3       40  

Total operating expenses

     3       40  

Operating income

     44       71  

Gain on divestiture

     500       —  

Net income from discontinued operations before income taxes

     544       71  

Provision for income taxes

     14       —  
                 

Net income from discontinued operations, net of taxes

   $ 530     $ 71  
   

For the years ended

December 31,

  
   

2025

    

2024

  
                 

Operating activities:

                

Net income from discontinued operations

   $ 530     $ 71  

Adjustments to reconcile net loss to net cash used in operating activities:

                

Non-cash gain on divestiture

     (500 )     —  

Changes in operating assets and liabilities:

                

Accounts receivable

     6       6  

Inventory

     43       12  

Accounts payable and accrued liabilities

     (38 )     (21 )

Net cash provided by operating activities, discontinued operations

     45       68  
                 

Investing activities:

                

Proceeds from divestiture

     500       —  

Net cash provided by investing activities, discontinued operations

     500       —  
                 

Net increase in cash and cash equivalents, discontinued operations

   $ 541     $ 68